05
Medicines for the treatment of gastrointestinal diseases;
pharmaceutical preparations and substances for the treatment
of gastrointestinal diseases; pharmaceutical preparations
for human use in the field of metabolic disorders, namely,
diabetes, obesity, hyperlipidemia, insulin resistance,
metabolic syndrome; pharmaceutical preparations for the
treatment of gastrointestinal disorders; pharmaceutical
preparations for the treatment of inflammation and
inflammatory diseases, namely inflammatory bowel diseases,
inflammatory connective tissue diseases, inflammatory pelvic
diseases; pharmaceutical preparations for the treatment of
mental health disorders
42
Clinical trials; conducting interventional clinical studies;
providing medical and scientific research information in the
field of pharmaceuticals and clinical trials; research in
the fields of clinical trials and post-market trials;
scientific research for the development of CRISPR-based
platforms and products in the field of genetic engineering
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen